Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 3Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Recurrence 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1HER2-positive Breast Cancer 1Gastroesophageal Junction Cancer 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Advanced Solid Tumors 1Advanced Pancreatic Cancer 1Advanced Non-small Cell Lung Cancer 1Advanced Non-Small Cell Lung Cancer 1Advanced Malignant Neoplasm 1Advanced Esophageal Carcinoma 1Advanced Breast Cancer 1

Interventions

Gemcitabine 5Radiotherapy, Intensity-Modulated 3Cisplatin 3tislelizumab 1Injections 1Endostatins 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Neoplasms × Docetaxel × Clear all
NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Shanghai JMT-Bio Inc.

Phase 2 Not yet recruiting
150 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡